Bayer Sees Innovation As Best Japan Growth Strategy
This article was originally published in PharmAsia News
Executive Summary
Bayer Yakuhin in Japan is aiming to grow three times faster than the overall pharma market in the country in 2015, mainly on the back of strong growth for Xarelto, Eylea and other new drugs.